Revive Therapeutics Stock Price, News & Analysis (CVE:RVV)

C$0.26 0.00 (0.00 %)
(As of 12/15/2017 02:51 PM ET)
Previous CloseC$0.26
Today's RangeC$0.24 - C$0.26
52-Week RangeC$0.10 - C$0.44
Volume455,183 shs
Average Volume813,950 shs
Market CapitalizationC$15.50 million
P/E RatioN/A
Dividend YieldN/A

About Revive Therapeutics (CVE:RVV)

Revive Therapeutics Ltd. focuses on the development and commercialization of various drugs in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-003, a tianeptine for treatment of Rett Syndrome; and REV-004, a bucillamine for the treatment of cystinurial, as well as REV-005 for the treatment of Wilson’s disease, which are under various stages of development. Revive Therapeutics Ltd. Revive Therapeutics Ltd. has a research agreement with the University of Wisconsin-Madison to evaluate a drug delivery technology with a focus on cannabinoids for the treatment of various diseases, such as pain and inflammation for the medical marijuana and pharmaceutical markets in Canada and the United States. It also has a research collaboration with Sanyal Biotechnology LLC to focus on advancing cannabinoids for the treatment of liver diseases. The company is based in Vaughan, Canada.

Receive RVV News and Ratings via Email

Sign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSC($0.03)
Net IncomeN/A
Net MarginsN/A
Return on Equity-117.56%
Return on Assets-101.29%


Outstanding Shares53,894,000

Revive Therapeutics (CVE:RVV) Frequently Asked Questions

What is Revive Therapeutics' stock symbol?

Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."

When will Revive Therapeutics make its next earnings announcement?

Revive Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Revive Therapeutics.

Who are some of Revive Therapeutics' key competitors?

Who are Revive Therapeutics' key executives?

Revive Therapeutics' management team includes the folowing people:

  • Craig Leon, Chairman of the Board, Chief Executive Officer
  • Fabio Chianelli, President, Director
  • Carmelo Marrelli, Chief Financial Officer, Secretary
  • Robbie Grossman, Director (Age 40)
  • Scott Johnson, Director (Age 36)
  • Anton Konovalov, Director (Age 26)
  • Reiza Rayman M.D., Director (Age 53)
  • Carlo Sansalone, Director (Age 35)

How do I buy Revive Therapeutics stock?

Shares of Revive Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Revive Therapeutics' stock price today?

One share of Revive Therapeutics stock can currently be purchased for approximately C$0.26.

How big of a company is Revive Therapeutics?

Revive Therapeutics has a market capitalization of C$15.50 million.

How can I contact Revive Therapeutics?

Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.

MarketBeat Community Rating for Revive Therapeutics (RVV)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  37
MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Revive Therapeutics (CVE:RVV) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Earnings History for Revive Therapeutics (CVE:RVV)

No earnings announcements for this company have been tracked by


Revive Therapeutics (CVE:RVV) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Revive Therapeutics (CVE:RVV)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Revive Therapeutics (CVE RVV)

No insider trades for this company have been tracked by


Revive Therapeutics (CVE RVV) News Headlines

Revive Therapeutics Ltd (RVV) to Release Quarterly Earnings on WednesdayRevive Therapeutics Ltd (RVV) to Release Quarterly Earnings on Wednesday - October 11 at 2:44 AM

SEC Filings

Revive Therapeutics (CVE:RVV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Revive Therapeutics (CVE RVV) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.